GSK Loses Bid To Get US FDA To Change Zofran Label, But May Prevail On Preemption Defense Anyway

 
• By Brenda Sandburg
  
Zofran
FDA denied citizen petition seeking review of information on Zofran use in pregnancy • Source: Alamy

More from US FDA

More from Agency Leadership